Cargando…

Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China

Detalles Bibliográficos
Autores principales: Chen, Yilin, Liu, Zelin, Zou, Jing, Wang, Danyu, He, Wenjuan, Meng, Li, Cheng, Fanjun, Zhang, Yanli, Li, Weiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335083/
https://www.ncbi.nlm.nih.gov/pubmed/35484651
http://dx.doi.org/10.3324/haematol.2022.280637
_version_ 1784759254847062016
author Chen, Yilin
Liu, Zelin
Zou, Jing
Wang, Danyu
He, Wenjuan
Meng, Li
Cheng, Fanjun
Zhang, Yanli
Li, Weiming
author_facet Chen, Yilin
Liu, Zelin
Zou, Jing
Wang, Danyu
He, Wenjuan
Meng, Li
Cheng, Fanjun
Zhang, Yanli
Li, Weiming
author_sort Chen, Yilin
collection PubMed
description
format Online
Article
Text
id pubmed-9335083
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-93350832022-08-26 Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China Chen, Yilin Liu, Zelin Zou, Jing Wang, Danyu He, Wenjuan Meng, Li Cheng, Fanjun Zhang, Yanli Li, Weiming Haematologica Letter to the Editor Fondazione Ferrata Storti 2022-04-28 /pmc/articles/PMC9335083/ /pubmed/35484651 http://dx.doi.org/10.3324/haematol.2022.280637 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter to the Editor
Chen, Yilin
Liu, Zelin
Zou, Jing
Wang, Danyu
He, Wenjuan
Meng, Li
Cheng, Fanjun
Zhang, Yanli
Li, Weiming
Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China
title Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China
title_full Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China
title_fullStr Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China
title_full_unstemmed Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China
title_short Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China
title_sort low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in china
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335083/
https://www.ncbi.nlm.nih.gov/pubmed/35484651
http://dx.doi.org/10.3324/haematol.2022.280637
work_keys_str_mv AT chenyilin lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT liuzelin lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT zoujing lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT wangdanyu lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT hewenjuan lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT mengli lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT chengfanjun lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT zhangyanli lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina
AT liweiming lowdosetyrosinekinaseinhibitorsinpatientswithchronicmyeloidleukemiaaretrospectivestudyinchina